The city of Dourados in Mato Grosso do Sul, Brazil, has commenced the nation’s inaugural mass vaccination against dengue, targeting approximately 150,000 residents aged 4 to 59. Utilizing the recently approved vaccine QDENGA from Japanese drugmaker Takeda, the initiative received its first batch of 90,000 doses as part of a collaboration with the Japanese laboratory. The vaccination schedule involves a second dose three months later. Dengue, transmitted by the Aedes aegypti mosquito, can have mild to severe forms, with symptoms including muscle weakness, vomiting, and diarrhea. Brazil, experiencing a surge in dengue cases, plans to incorporate Takeda’s vaccine into the national vaccination program, initially focusing on priority groups and regions due to limited supply. Additional doses are expected between February and November.
Related Posts
Congo fever case diagnosed in city, patient under treatment.
- Ibtehaj Tahir
- September 6, 2024
- 0
A 55-year-old man has been diagnosed with Congo fever in the city, according to Dunya News. The patient was admitted to the Fatima Jinnah Institute, […]
Promising reakthrough in cancer treatment: nanobots developed to target and kill cancer cells.
- Ibtehaj Tahir
- July 26, 2024
- 0
In a promising development for cancer treatment, researchers have created nanobots that have demonstrated the ability to kill cancer cells in mice. Previously, researchers at […]
Chickenpox outbreak causes panic in upper Chitral girls’ school.
- Ibtehaj Tahir
- September 2, 2023
- 0
Panic Strikes Upper Chitral as Chickenpox Outbreak Hits Girls’ School in Harchin” Residents of Upper Chitral were alarmed on Friday as local authorities confirmed a […]